Fifteen PNNL scientists are part of a team that has identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.
PNNL scientists are part of a nationwide effort to learn more about the role of proteins in cancer biology and to use that information to benefit cancer patients.